Bottom Fish Stocks (between .10 and$10)

[smoke]

NVD post from another board:
Ongoing performance payments of seventeen percent (17%) of net sales on a market of $200mm assuming a 30% market share is about $10mm annually in NVD revenue, but most important feature is that Akrimax Pharmaceuticals, LLC will receive the exclusive right to manufacture, distribute, market and sell NitroMist(R) in North America, thus not cost of sales for NVD, it all shld drop to bottom line excluding impact of ongoing R&D for pipeline. Assuming 50% is reinvested and $5mm drops to net income times a 10x P/E multiple, enterprise value of nitro deal alone should be about $50mm or about $0.75-$0.80 per share